Scientists discover effects of PD-1 blockade on ART therapy in SIV-infected monkeys
Scientists have discovered that blocking PD-1 (programmed death-1), an immune molecule that inhibits the immune response to viral infections, can have a significant effect on HIV-like illness in nonhuman primates.
In earlier research, the scientists showed that PD-1 blockade could restore T and B cell function against SIV. Now they have new findings about the effects of PD-1 blockade along with antiretroviral therapy (ART).
Vijayakumar Velu, PhD, a scientist at Yerkes National Primate Research Center and the Emory Vaccine Center presented the information at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle, Wash. Rama Rao Amara, PhD, associate professor of microbiology and immunology at Yerkes and the Emory Vaccine Center, led the project.
The researchers treated SIV-infected rhesus macaque monkeys with ART from 16 to 21 weeks post infection then interrupted the therapy. The SIV viral load rapidly increased, along with the frequency of SIV-specific CD8 T cells. Four weeks later, the researchers treated some of the macaques with anti-PD-1 antibody and monitored both the treated and control animals.
Half the animals treated with PD-1 blockade, but only those with measurable CD8 T cells at the time of ART interruption, had a rapid decline in plasma viral load. PD-1 blockade did not enhance the frequency of SIV-specific CD8 T cells, but rather enhanced their function.
"Our results show PD-1 blockade after ART interruption can significantly enhance viral control, but the effect seems to depend on maintaining measurable SIV-specific CD8 T cell response following therapy," says Velu.
Rafi Ahmed, director of the Emory Vaccine Center and a key member of this research team, first identified the PD-1 molecule as a target for therapy designed to reactivate exhausted immune cells in chronic diseases. Other members of the research team are Gordon J. Freeman of Harvard Medical School and Kehmia Titanji, Ravi Dyavar Shetty and Hyun Woo Lee from Yerkes and the Emory Vaccine Center. The team plans to continue studying the interactive effects of PD-1 blockade combined with ART.
Holly Korschun | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...